Kevin M. Slawin, Chief Technology Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 55,000 shares at $11.42 ($628K) on 2016-04-22, disclosed to the SEC on 2016-04-26.
Open-market sale of $628k BLCM by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.42 | 29,800 | $340K | 54.2% |
| 2 | $11.43 | 25,000 | $286K | 45.5% |
| 3 | $11.89 | 200 | $2K | 0.4% |
| Total | $11.43 avg | 55,000 | $628K | 100% |
| Filing → |
| BLCM | SELL | 2016-09-23 | $936K | — | Filing → |
| BLCM | SELL | 2016-09-20 | $92K | — | Filing → |
| BLCM | SELL | 2016-08-17 | $2.0M | — | Filing → |